Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through two segments, MedSurg and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions, such as resolution clips, biliary stent systems, stents and electrocautery enhanced delivery systems, direct visualization systems, digital catheters, and single-use duodenoscopes; devices to treat urological conditions, including ureteral stents, catheters, baskets, guidewires, sheaths, balloons, single-use digital flexible ureteroscopes, holmium laser systems, artificial urinary sphincter, laser system, fiber, and hydrogel systems; and devices to treat neurological movement disorders and manage chronic pain, such as spinal cord stimulator system, proprietary programming software, radiofrequency generator, indirect decompression systems, practice optimization tools, and deep brain stimulation system. It also provides technologies for diagnosing and treating coronary artery disease and aortic valve conditions; WATCHMAN FLX, a Left Atrial Appendage Closure Device; and implantable devices that monitor the heart and deliver electricity to treat cardiac abnormalities, such as cardioverter and cardiac resynchronization therapy defibrillators, MRI S-ICD systems, cardiac resynchronization therapy pacemakers, quadripolar LV leads, ICD leads, pacing leads, remote patient management systems, insertable cardiac monitor systems, and remote cardiac monitoring systems. In addition, the company offers diagnosis and treatment of rate and rhythm disorders of the heart; peripheral arterial and venous diseases; and products to diagnose, treat and ease forms of cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts. more
Time Frame | BSX | Sector | S&P500 |
---|---|---|---|
1-Week Return | -1.95% | -3.35% | -2.97% |
1-Month Return | -1.85% | -3.49% | -0.66% |
3-Month Return | 5.91% | -12.6% | 2.71% |
6-Month Return | 15.14% | -6.91% | 7.21% |
1-Year Return | 58.83% | 1.19% | 23.04% |
3-Year Return | 124.46% | -0.21% | 28.43% |
5-Year Return | 97.77% | 33.09% | 82.88% |
10-Year Return | 574.22% | 93.55% | 184.63% |
Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | 5YR TREND | |
---|---|---|---|---|---|---|
Total Revenue | 10.73B | 9.91B | 11.89B | 12.68B | 14.24B | [{"date":"2019-12-31","value":75.39,"profit":true},{"date":"2020-12-31","value":69.61,"profit":true},{"date":"2021-12-31","value":83.48,"profit":true},{"date":"2022-12-31","value":89.06,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Cost of Revenue | 3.18B | 3.51B | 3.76B | 4.00B | 4.34B | [{"date":"2019-12-31","value":73.21,"profit":true},{"date":"2020-12-31","value":80.78,"profit":true},{"date":"2021-12-31","value":86.54,"profit":true},{"date":"2022-12-31","value":92.13,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Profit | 7.55B | 6.40B | 8.13B | 8.68B | 9.89B | [{"date":"2019-12-31","value":76.34,"profit":true},{"date":"2020-12-31","value":64.71,"profit":true},{"date":"2021-12-31","value":82.14,"profit":true},{"date":"2022-12-31","value":87.71,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Gross Margin | 70.37% | 64.59% | 68.37% | 68.44% | 69.49% | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":91.79,"profit":true},{"date":"2021-12-31","value":97.16,"profit":true},{"date":"2022-12-31","value":97.25,"profit":true},{"date":"2023-12-31","value":98.75,"profit":true}] |
Operating Expenses | 5.81B | 5.72B | 6.30B | 6.65B | 7.55B | [{"date":"2019-12-31","value":76.99,"profit":true},{"date":"2020-12-31","value":75.73,"profit":true},{"date":"2021-12-31","value":83.47,"profit":true},{"date":"2022-12-31","value":88,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Operating Income | 1.52B | 1.04B | 2.04B | 1.65B | 2.34B | [{"date":"2019-12-31","value":64.79,"profit":true},{"date":"2020-12-31","value":44.56,"profit":true},{"date":"2021-12-31","value":87.2,"profit":true},{"date":"2022-12-31","value":70.38,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Total Non-Operating Income/Expense | (1.27B) | (1.48B) | (464.00M) | (978.00M) | (612.00M) | [{"date":"2019-12-31","value":-127400000000,"profit":false},{"date":"2020-12-31","value":-148400000000,"profit":false},{"date":"2021-12-31","value":-46400000000,"profit":false},{"date":"2022-12-31","value":-97800000000,"profit":false},{"date":"2023-12-31","value":-61200000000,"profit":false}] |
Pre-Tax Income | 687.00M | (138.00M) | 1.08B | 1.14B | 1.99B | [{"date":"2019-12-31","value":34.61,"profit":true},{"date":"2020-12-31","value":-6.95,"profit":false},{"date":"2021-12-31","value":54.21,"profit":true},{"date":"2022-12-31","value":57.48,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
Income Taxes | (4.01B) | 2.00M | 36.00M | 443.00M | 393.00M | [{"date":"2019-12-31","value":-905.87,"profit":false},{"date":"2020-12-31","value":0.45,"profit":true},{"date":"2021-12-31","value":8.13,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":88.71,"profit":true}] |
Income After Taxes | 4.70B | (140.00M) | 1.04B | 698.00M | 1.59B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-2.98,"profit":false},{"date":"2021-12-31","value":22.13,"profit":true},{"date":"2022-12-31","value":14.85,"profit":true},{"date":"2023-12-31","value":33.87,"profit":true}] |
Income From Continuous Operations | 4.70B | (81.00M) | 1.04B | 698.00M | 1.23B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-1.72,"profit":false},{"date":"2021-12-31","value":22.15,"profit":true},{"date":"2022-12-31","value":14.85,"profit":true},{"date":"2023-12-31","value":26.13,"profit":true}] |
Income From Discontinued Operations | - | - | - | - | - | [{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}] |
Net Income | 4.70B | (140.00M) | 1.04B | 698.00M | 1.59B | [{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-2.98,"profit":false},{"date":"2021-12-31","value":22.15,"profit":true},{"date":"2022-12-31","value":14.85,"profit":true},{"date":"2023-12-31","value":33.89,"profit":true}] |
EPS (Diluted) | 1.59 | 0.96 | 1.63 | 1.75 | 2.05 | [{"date":"2019-12-31","value":77.56,"profit":true},{"date":"2020-12-31","value":46.83,"profit":true},{"date":"2021-12-31","value":79.51,"profit":true},{"date":"2022-12-31","value":85.37,"profit":true},{"date":"2023-12-31","value":100,"profit":true}] |
These ratios help you determine the liquidity of the company. Higher is better.
BSX | |
---|---|
Cash Ratio | 0.42 |
Current Ratio | 1.48 |
Quick Ratio | 1.02 |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
BSX | |
---|---|
ROA (LTM) | 4.90% |
ROE (LTM) | 8.92% |
These ratios help you understand the company's liabilities, gauging the riskiness of the investment.
BSX | |
---|---|
Debt Ratio Lower is generally better. Negative is bad. | 0.45 |
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. | 0.54 |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
BSX | |
---|---|
Trailing PE | 72.75 |
Forward PE | 32.26 |
P/S (TTM) | 8.15 |
P/B | 6.44 |
Price/FCF | 186 |
EV/R | 8.93 |
EV/Ebitda | 38.12 |
PEG | 1.64 |
Boston Scientific Corp (BSX) share price today is $88.66
Yes, Indians can buy shares of Boston Scientific Corp (BSX) on Vested. To buy Boston Scientific Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BSX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of Boston Scientific Corp (BSX) via the Vested app. You can start investing in Boston Scientific Corp (BSX) with a minimum investment of $1.
You can invest in shares of Boston Scientific Corp (BSX) via Vested in three simple steps:
The 52-week high price of Boston Scientific Corp (BSX) is $91.93. The 52-week low price of Boston Scientific Corp (BSX) is $54.95.
The price-to-earnings (P/E) ratio of Boston Scientific Corp (BSX) is 74.7355
The price-to-book (P/B) ratio of Boston Scientific Corp (BSX) is 6.44
The dividend yield of Boston Scientific Corp (BSX) is 0.00%
The market capitalization of Boston Scientific Corp (BSX) is $133.28B
The stock symbol (or ticker) of Boston Scientific Corp is BSX